Invention Grant
US09096644B2 Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use
有权
抗原诺如病毒P结构域单体和二聚体,抗原诺如病毒P颗粒分子及其制备和使用方法
- Patent Title: Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use
- Patent Title (中): 抗原诺如病毒P结构域单体和二聚体,抗原诺如病毒P颗粒分子及其制备和使用方法
-
Application No.: US13924906Application Date: 2013-06-24
-
Publication No.: US09096644B2Publication Date: 2015-08-04
- Inventor: Ming Tan , Xi Jiang
- Applicant: Children's Hospital Medical Center
- Applicant Address: US OH Cincinnati
- Assignee: Children's Hospital Medical Center
- Current Assignee: Children's Hospital Medical Center
- Current Assignee Address: US OH Cincinnati
- Agency: Frost Brown Todd LLC
- Main IPC: C07K7/06
- IPC: C07K7/06 ; A61K38/00 ; A61K39/12 ; A61K39/125 ; C07K5/10 ; A61K39/00

Abstract:
A substituted Norovirus capsid protein monomer, having only the P-domain, includes a foreign antigen inserted into one or more of three surface loops present on each P-domain monomer by molecular cloning. The antigen-P-domain monomer can assemble spontaneously into an octahedral, antigen-Norovirus P-particle, composed of 24 copies of the monomer. Each substituted P-domain monomer can contain one to three copies of the foreign antigen, for a total of 24-72 antigen copies on each antigen-P-particle. The antigen-P-particle is useful in methods for diagnosing, immunizing and treating individuals infected with a foreign virus and as a carrier for development of vaccines against many infectious and non-infectious diseases. The substituted monomer can be readily produced in E. coli and yeast, are highly stable and tolerate a wide range of physio-chemical conditions. The P-particle-VP8 chimeras may also serve as a dual vaccine, for example, against both rotavirus and norovirus.
Public/Granted literature
Information query